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Background: Although the pathogenic role of Coxiella burnetii infection during pregnancy is controversial, some
cases of stillbirth and abortion occurringafter an acute or chronic infection have been mentioned in the literature.
Recently, Q fever has been advocated as a significant cause of morbidity and mortality in pregnancy
Case: We describe an 18-year-old primipara woman admitted to our hospital for high fever and pancytopenia
during an acute C. burnetii infection. She was successfully treated with clarithromycin, overcoming fever and
pancytopenia. Finally, she gave birth to a healthy infant, and 1 year later both remained well.
Conclusion: Q fever is a potentially serious disease in pregnancyowing to the possibility of placenta infection and
fetal transmission affecting its outcome. Q fever infection should be suspected in unexplained febrile episodes or
abortion during pregnancy,when epidemiologic and clinical data are present.We believe that C. burnetii serology
should be tested in cases of fever of known origin or unexplained abortions, as the TORCH infections are.
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Q fever is a worldwide zoonosis caused by a
Gram-negative obligate intracellular bacterium,
Coxiella burnetii. Frequently, it is a self-limited
febrile episode or occurs in association with
pneumonia1. Both domesticated and wild animals
have been demonstrated to have reservoirs of the
infection in their placenta,whichacts as thesource
of contamination via the aerosol route at the time
of parturition2. Here we describe a woman preg-
nant for 20 weeks admitted to our hospital with
fever and pancytopenia during an acute C. burnetii
infection.
An 18-year-old primipara woman was hospital-
ized because of high fever and chills during the
previous week. She lived in the countryside and
worked as a farmer. Physical examination revealed
a pale patient with fever (temperature 39°C). No
other remarkable data were detected. Laboratory
studies showed a marked pancytopenia (hemo-
globin 8.62 g/dl, white blood cell count (WBC)
3250 cell/ml, and platelet count 90 400 cell/ml).
Other laboratory results are shown in Table 1.
Microbiologic cultures from blood, urine and
amniotic fluid were aseptic. There was no
serologic evidence for recent infection with
Salmonella, Epstein–Barr virus, cytomegalovirus,
Brucella, human immunodeficiency virus
(HIV), syphilis, toxoplasma, B-19 parvovirus,
Borrelia burgdorferi, Coxiella burnetii, Rickettsia
conorii or Leishmania. Chest radiograph and
abdominal echography yielded normal findings.
She received empirical antibiotic therapy with
ampicillin, gentamicin and clindamycin, but fever
continued.
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increased, so a twice-per-day clarithromycin
regimen (500 mg) was initiated. Forty-eight hours
later, fever disappeared and hematologic and bio-
chemical parameters became normal. One month
later, a significant rise in the indirect immuno-
fluorescence (IFI) phase II antibody titers (1/512)
of C. burnetii was detected, and retrospectively an
acute Q fever was diagnosed. After 40 weeks of
pregnancy,she gave birth to a healthy child. Now,
1 year later, the patient and her baby are well.
Maternal infection may present as acute Q fever
or chronic uteroplacental infection reactivated by
the immunocompromised state associated with
pregnancy. Although the pathogenesis of fetal
disease is less well known, immunocomplex
formed may cause vasculitis and vascular throm-
bosis occasioning placental insufficiency, respon-
sible for prematurity and abortion. Fetal direct
infection has been proved in some cases in which
C.burnetiiwasisolated fromseveral fetalviscera2.
Recently, Stein and Raoult collected all cases
published until 1998, demonstrating that Q fever
can be a significant cause of morbidity and mortal-
ity in pregnancy2. In only five of the 23 cases
reported was a healthy child born. There were
eight cases of premature birth, eight cases of abor-
tion and five cases of neonatal death within 2 days.
Diagnosis was made by serology in all cases,
demonstrating an acute infection in 14 and a
typical chronic profile in nine. In 12 of 17 cases,
C. burnetii has been identified in the placenta by
culture. There was a case of nosocomial trans-
mission of the disease to theobstetrician who took
care of the birth, caused by aerosolization of the
microorganism from the infected placenta3.
With respect to treatment, although many
controlledclinicaltrialscomparingantibioticshave
been performed, clinical experience seems to
accord with in vitro susceptibility4. It seems that in
cases of acute infection a bacteriostatic effect is
sufficient, whereas in cases of chronic infection a
bactericide effect is necessary. The selection of an
antimicrobial treatment in pregnancy is contro-
versial. Tetracycline, the first-choice agent, has
beenrelated to maternalhepatotoxicity,fetaltooth
discoloration and retarded skeletal bone maturity.
Macrolides have a bacteriostatic effect comparable
to that of other antibiotics and might be an alter-
native5. Although the efficacy of quinolones
against C. burnetii has not yet been established,
ciprofloxacin has shown in vitro susceptibility test-
ing comparable or superior to that of conventional
drugs.In addition, it crosses theplacenta and is safe
in pregnancy4. Nevertheless, because the activity
ofantibioticsismodest,itseems reasonable,mainly
in cases of chronic infection, to associate several
drugs by analogy with endocarditis, in which the
synergic association of doxycycline and rifampicin
or ciprofloxacin has reduced mortality6.
Hematologic complications of Q fever occur
infrequently and include hemolytic anemia from
cold agglutinins and thrombocytopenia associated
with endocarditis. We emphasize the severe
pancytopenia in our case that yielded to clinical
improvement. This complication has been
attributedtoa hemophagocyticsyndrome.Hemo-
phagocytosis is an unusual cause of increased
consumption of mature sanguineous cells second-
ary to neoplasic or infectious conditions. Two
cases ofhemophagocytosisinnonpregnantpatients
have been described as a complication of acute Q
fever7,8. Bacterial lipopolysaccharides and some
cytoquines have been related to activation of
macrophages and secondary phagocytosis. Only
one of the 23 cases diagnosed during pregnancy
presented with pancytopenia suggestive of
hemophagocytosis.
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Test Value
Erythrocyte sedimentation rate
C-reactive protein level
Hemoglobin level
Reticulocyte counts
Platelet counts
White blood cell (WBC) count
Alanine aminotransferase level
Aspartate aminotransferase level
g-Glutamyltransferase level
Alkaline phosphatase level
Bilirubin level
Lactate dehydrogenase level
Antinuclear antibodies
Anti-DNA antibodies
50 mm/h
5.8 mg/dl
8.62 g/dl
1%
90 400/ml
3250 ml
370 U/l
467 U/l
23 U/l
240 U/l
0.7 mg/dl
725 U/l
Negative
Negative
Table 1 Results of laboratory testsIn summary, Q fever is a potentially serious
disease in pregnancy because of the possibility of
placenta infection and fetal transmission. It is
advisable for pregnant women to avoid parturient
animals, including domestic ones. Diagnosis is
helpful not only for the high risk of prematurity
and abortion but also for the clinicians attending
delivery (nosocomial transmission). Because
maternal incidence might be higher than
expected2, Q fever should be suspected in cases of
fever of unknown origin during pregnancy or
unexplained abortion when epidemiologic and
clinical data are concordant. We think that
C. burnetii serology should be tested and repeated
for seroconversion in unexplained fever or
abortions, as the TORCH infections are.
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